Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2010
05/19/2010EP2184995A2 Composites for biomedical applications
05/19/2010EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy
05/19/2010EP1438063B1 Glutation precursors for the treatment of neuropsychiatric disorders
05/19/2010EP1435994B1 Novel use of pulmonary surfactant
05/19/2010EP1368060B1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
05/19/2010EP1365795B1 Use of the g-csf as additional treatment in the reconstruction of connective tissue
05/19/2010EP1208233B1 Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q
05/19/2010CN1957920B Anti cancer slow release agent carrying fluorouracil and synergist
05/19/2010CN1939343B Bone-peptide sodium chloride injection and its making method
05/19/2010CN101711284A Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
05/19/2010CN101711255A Modified globin proteins with altered electron transport pathway
05/19/2010CN101709321A Oat polypeptide, preparation method thereof and application thereof
05/19/2010CN101709292A Recombinant adenovirus, and preparation method and application thereof
05/19/2010CN101709083A Fibrinolytic protein from scorpion tails, preparation method and application thereof
05/19/2010CN101709078A immune-modulating peptide
05/19/2010CN101709076A Method for preparing hoof nail polypeptide
05/19/2010CN101708329A Product preparation for medical leech and new application of medical leech
05/19/2010CN101708328A Pharmaceutical application of CYR61 protein
05/19/2010CN101245344B Eriocheir sinensis lipotropism polyoses factor gene and encoding protein and application
05/19/2010CN101139569B alpha-amylase inhibitor production bacterium and method for preparing alpha-amylase inhibitor and application
05/19/2010CN101130068B SOD slimming wine and its production process
05/19/2010CN101113448B Agkistrodon halys ussuriensis disintegrin site-directed mutants cDNA clone, expression and protein preparation method and application thereof
05/19/2010CN101066278B Medicine use of energy mixture
05/19/2010CN101063130B Recombined protein having phenotypic knock-out effect on chemotropism factor receptor CXCR4 and its construction method
05/19/2010CN101063103B Hainan sporic scorpion antibiotic and preparation method and application
05/19/2010CN101032620B Cyclosporine emulsion and the preparing method
05/19/2010CN101015686B Thrombolytic medicine synergist and its preparing process
05/18/2010US7718824 Therapeutic stem cell growth factor composition, anti-inflammatory composition, and uses thereof
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718773 treatment of hyperphosphataemia and cardiovascular diseases or arthritis
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718769 Tri-peptide hepatitis C serine protease inhibitors
05/18/2010US7718768 Biologically active peptide PTTKTYFPHF
05/18/2010US7718765 orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc)
05/18/2010US7718764 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
05/18/2010US7718763 Substrate polyeptides for von Willebrand factor cleaving protease ADAMTS-13
05/18/2010US7718762 stimulate T cytotoxic lymphocytes in a mammal
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718697 Method for treating glaucoma comprising administering α-lipoic acid
05/18/2010US7718691 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
05/18/2010US7718622 freezing dried biochemical conjugated immunomodulator comprising immunostimulatory polynucleotide sequence and plant Ragweed allergen; genetic vaccines
05/18/2010US7718620 Methods for preventing or treating ischemia-reperfusion injury of the kidney
05/18/2010US7718619 Abuse-resistant amphetamine prodrugs
05/18/2010US7718618 preventing, treating a viral infection with a polypeptide biodrug; caused by poxvirus, herpes virus, vaccinia virus, and papillomavirus; treating atopic dermatitis
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718615 Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
05/18/2010US7718614 Combination therapy of peptide vaccination and estramustine treatment
05/18/2010US7718613 Armed peptides
05/18/2010US7718612 Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
05/18/2010US7718611 Cyclic nonapeptide amides
05/18/2010US7718610 Retrocyclins: antiviral and antimicrobial peptides
05/18/2010US7718609 Rapid acting and long acting insulin combination formulations
05/18/2010US7718607 Method of producing S-nitrosoprotein preparation
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718604 Use of IL-22 for the treatment of conditions of metabolic disorders
05/18/2010US7718603 Selective targeting agents for mitochondria
05/18/2010US7718602 High beta-conglycinin products and their use
05/18/2010US7718601 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors
05/18/2010US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases
05/18/2010US7718428 using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficial
05/18/2010US7718412 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin
05/18/2010US7718406 benzoyl-(L)-lysyl-( epsilon -benzyloxycarbonyl)- alpha -(D,L)-(2-guanidinoethylthio)-glycine hydrochloride salt ; substrate for the detection of TAFIa (thrombin-activatable fibrinolysis inhibitor) , a fibrinolysis inhibiting enzyme
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718400 for increasing insulin sensitivity; decreasing the dose of insulin required for the treatment of diabetes; controlling serum glucose levels; increasing lean tissue mass; increasing overall body strength; and regulating bone resorption
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010US7718386 Methods for the diagnosis of diabetes
05/18/2010US7718384 Soluble ErbB3 method of detection
05/18/2010US7718192 Tamper-resistant oral opioid agonist formulations
05/18/2010US7718190 Self forming, thermodynamically stable liposomes and their applications
05/18/2010US7718178 Allergen formulation
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718176 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010US7718171 Use of composition obtainable by fermenting food material comprising animal milk or vegetable proteins with a lactic acid bacterium to obtain a fermented food material which comprises peptides or other active components with heart rate reducing properties
05/18/2010US7718170 Alkaline phosphatase compositions to reduce skin cancer
05/18/2010US7718169 Compositions and methods for treating pancreatic insufficiency
05/18/2010US7718168 Mixture of transglutaminase binding protein and polymer; artificial bones
05/18/2010US7718163 Includes additive material on the surfaces of the carrier particles to promote the release of the active particles from the carrier particles on actuation of the inhaler; an inhalant includes crystalline milk sugar carrier,leucine additive and beclomethasone dipropionate inhalant
05/18/2010US7718161 Method for treating a motoneuron disorder
05/18/2010CA2473205C Orodispersible pharmaceutical composition comprising perindopril
05/18/2010CA2402193C Novel lhrh-antagonists, production and use thereof as medicament
05/18/2010CA2378543C Modified human granulocyte-colony stimulating factor and process for producing same
05/18/2010CA2363965C Protein-induced morphogenesis
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2296409C Agents comprising midkine or its inhibitor as active ingredient
05/18/2010CA2288709C Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/18/2010CA2171266C Stable transglutaminase preparations and processes for producing them
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/18/2010CA1341605C Synthetic antigen for the detection of aids-related disease
05/17/2010CA2686135A1 Chimeric hirudin proteins
05/14/2010WO2010054403A1 Methods and compositions for treating complement-associated disorders
05/14/2010WO2010054381A2 Method of treating cancer with a combination of a proteasome inhibitor and salubrinal
05/14/2010WO2010054324A2 Methods for treating clinical conditions associated with lipoprotein lipase activity
05/14/2010WO2010054316A2 Endothelium mimicking nanomatrix
1 ... 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 ... 3163